10.28.2024 - POLA

from QuadShot News Podcast · host Caleb Dulaney, Sam Marcrom, Laura Dover

Check out this week's QuadCast as we discuss if PCV is better than TMZ for oligodendroglioma, discuss results of the hypo-FLAME trial for prostate cancer, highlight adjuvant RT for high risk bladder cancer in the BART trial, and more. Check out the website and subscribe to the newsletter! www.quadshotnews.com Founders & Lead Authors: Laura Dover & Caleb Dulaney Podcast Host: Sam Marcrom

Episode metadata supplied by the publisher feed · Published Oct 28, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Distinct summary based on available episode metadata or transcript content.

Ready to play

10.28.2024 - POLA

0:00 10:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

The Foods Better Than Ozempic

Jan 21, 2025 ·48m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of QuadShot News Podcast?

This episode is 10 minutes long.

When was this QuadShot News Podcast episode published?

This episode was published on October 28, 2024.

Can I download this QuadShot News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!